Jubilant Pharmova Limited (JUBLPHARMA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.056x

Based on the latest financial reports, Jubilant Pharmova Limited (JUBLPHARMA) has a cash flow conversion efficiency ratio of 0.056x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.69 Billion ≈ $39.91 Million USD) by net assets (Rs65.72 Billion ≈ $710.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See JUBLPHARMA equity financing ratio to measure how much of total assets are equity-financed.

Jubilant Pharmova Limited - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Jubilant Pharmova Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Jubilant Pharmova Limited (JUBLPHARMA) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Jubilant Pharmova Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jubilant Pharmova Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zhejiang Expressway Co. Ltd F:ZHJ	0.012x
China TransInfo Technology Co Ltd SHE:002373	0.022x
Guangdong Marubi Biotechnology Co SHG:603983	0.012x
Pan Jit International Inc TW:2481	0.045x
Godawari Power And Ispat limited NSE:GPIL	0.076x
Huron Consulting Group Inc NASDAQ:HURN	-0.408x
Zhejiang Medicine Co Ltd SHG:600216	0.061x
Atrium Ljungberg AB (publ) ST:ATRLJ-B	0.005x

Annual Cash Flow Conversion Efficiency for Jubilant Pharmova Limited (2004–2025)

The table below shows the annual cash flow conversion efficiency of Jubilant Pharmova Limited from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see JUBLPHARMA market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs62.39 Billion ≈ $674.68 Million	Rs10.72 Billion ≈ $115.94 Million	0.172x	-4.09%
2024-03-31	Rs54.21 Billion ≈ $586.27 Million	Rs9.71 Billion ≈ $105.04 Million	0.179x	+46.22%
2023-03-31	Rs53.92 Billion ≈ $583.10 Million	Rs6.61 Billion ≈ $71.45 Million	0.123x	-22.22%
2022-03-31	Rs53.16 Billion ≈ $574.95 Million	Rs8.38 Billion ≈ $90.58 Million	0.158x	-58.14%
2021-03-31	Rs47.42 Billion ≈ $512.78 Million	Rs17.84 Billion ≈ $192.96 Million	0.376x	+36.67%
2020-03-31	Rs56.04 Billion ≈ $606.04 Million	Rs15.43 Billion ≈ $166.86 Million	0.275x	+18.06%
2019-03-31	Rs48.09 Billion ≈ $520.08 Million	Rs11.22 Billion ≈ $121.29 Million	0.233x	-27.79%
2018-03-31	Rs40.35 Billion ≈ $436.37 Million	Rs13.03 Billion ≈ $140.94 Million	0.323x	-13.51%
2017-03-31	Rs33.97 Billion ≈ $367.35 Million	Rs12.68 Billion ≈ $137.18 Million	0.373x	-0.53%
2016-03-31	Rs29.10 Billion ≈ $314.66 Million	Rs10.92 Billion ≈ $118.13 Million	0.375x	+17.60%
2015-03-31	Rs24.54 Billion ≈ $265.34 Million	Rs7.83 Billion ≈ $84.71 Million	0.319x	+10.75%
2014-03-31	Rs27.84 Billion ≈ $301.13 Million	Rs8.03 Billion ≈ $86.80 Million	0.288x	-22.56%
2013-03-31	Rs26.06 Billion ≈ $281.82 Million	Rs9.70 Billion ≈ $104.90 Million	0.372x	+26.19%
2012-03-31	Rs23.99 Billion ≈ $259.41 Million	Rs7.08 Billion ≈ $76.52 Million	0.295x	+68.29%
2011-03-31	Rs22.14 Billion ≈ $239.44 Million	Rs3.88 Billion ≈ $41.97 Million	0.175x	-44.69%
2010-03-31	Rs22.39 Billion ≈ $242.17 Million	Rs7.10 Billion ≈ $76.74 Million	0.317x	-28.02%
2009-03-31	Rs12.68 Billion ≈ $137.08 Million	Rs5.58 Billion ≈ $60.35 Million	0.440x	+21.03%
2008-03-31	Rs12.56 Billion ≈ $135.85 Million	Rs4.57 Billion ≈ $49.42 Million	0.364x	+72.91%
2007-03-31	Rs9.06 Billion ≈ $98.00 Million	Rs1.91 Billion ≈ $20.62 Million	0.210x	+1147.30%
2006-03-31	Rs8.41 Billion ≈ $90.93 Million	Rs141.82 Million ≈ $1.53 Million	0.017x	-92.38%
2005-03-31	Rs5.04 Billion ≈ $54.56 Million	Rs1.12 Billion ≈ $12.08 Million	0.221x	-44.92%
2004-03-31	Rs2.10 Billion ≈ $22.69 Million	Rs843.14 Million ≈ $9.12 Million	0.402x	--

About Jubilant Pharmova Limited

NSE:JUBLPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$1.73 Billion

Rs159.62 Billion INR

Market Cap Rank

#6591 Global

#320 in India

Share Price

Rs1007.80

Change (1 day)

-1.57%

52-Week Range

Rs807.65 - Rs1236.30

All Time High

Rs1269.00